Search Results - "Morant, V A"

Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? : Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications by CHUNG, M. K, SCHWEIKERT, R. A, TCHOU, P. J, WILKOFF, B. L, NIEBAUER, M. J, PINSKI, S. L, TROHMAN, R. G, KIDWELL, G. A, JAEGER, F. J, MORANT, V. A, MILLER, D. P

“…We sought to determine the yield of in-hospital monitoring for detection of significant arrhythmia complications in patients starting sotalol therapy for…”
Get full text

Nonthoracotomy- versus thoracotomy-implantable defibrillators : intention-to-treat comparison of clinical outcomes by KLEMAN, J. M, CASTLE, L. W, KIDWELL, G. A, MALONEY, J. D, MORANT, V. A, TROHMAN, R. G, WILKOFF, B. L, MCCARTHY, P. M, PINSKI, S. L

“…Nonthoracotomy-implantable cardioverter/defibrillator (ICD) systems may represent a significant advance in the treatment of patients with life-threatening…”
Get full text

Patients with a high defibrillation threshold: clinical characteristics, management, and outcome by Pinski, S L, Vanerio, G, Castle, L W, Morant, V A, Simmons, T W, Trohman, R G, Wilcoff, B L, Maloney, J D

“…Of 125 patients prepared to receive implantable cardioverter-defibrillators (ICDs) with the patch-patch configuration of the difibrillating electrodes, 23…”
Get more information

Durability of bipolar coaxial endocardial pacemaker leads compared with unipolar leads by Helguera, M E, Pinski, S L, Maloney, J D, Woscoboinik, J R, Trohman, R G, Morant, V A, Wilkoff, B L, Castle, L W

“…The coaxial design allows for thinner bipolar endocardial pacemaker leads, but recent reports have suggested a higher incidence of failure for this…”
Get more information

Transcatheter electrical AV junction ablation: predictors of success by Simmons, T W, Nagi, H M, Wilkoff, B L, Morant, V A, Sterba, R, Castle, L W, Maloney, J D

“…The initial and long-term results of transcatheter electrical ablation in 29 patients with drug-refractory supraventricular tachyarrhythmias were analyzed…”
Get more information

Pacemaker and defibrillator combination therapy for recurrent ventricular tachycardia by Masterson, M, Pinski, S L, Wilkoff, B, Simmons, T W, Morant, V A, Golding, L R, Castle, L W, Maloney, J D

“…The judicious use of antitachycardia pacemakers can enhance the benefits of automatic implantable cardioverter defibrillators in certain patients. Both devices…”
Get more information

Cardiopulmonary effects of chronic amiodarone therapy in the early postoperative course of cardiac surgery patients by Tuzcu, E M, Maloney, J D, Sangani, B H, Masterson, M L, Hocevar, K D, Golding, L A, Starr, N J, Golish, J A, Castle, L W, Morant, V A

Get more information

Atrial pacemaker leads compared by Masterson, M M, Maloney, J D, Tuzcu, E M, Wilkoff, B L, Emre, A, Vanerio, G, Simmons, T W, Morant, V A, Castle, L W

“…In order to analyze the impact of different polarity and electrode designs on the acute pacing and sensing characteristics of pacemaker leads, 80 patients with…”
Get more information

Potassium loading as adjunct treatment of repetitive ventricular arrhythmias by Maloney, J D, Detrano, R, Jaeger, F J, Leatherman, J, Morant, V A, Castle, L W

“…To evaluate potassium supplementation as adjunct therapy for ventricular arrhythmias, consecutive normokalemic patients undergoing in-hospital antiarrhythmic…”
Get more information

Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems by Fahy, G J, Kleman, J M, Wilkoff, B L, Morant, V A, Pinski, S L

“…Implantable cardioverter defibrillators (ICDs) are increasingly being implanted without the need for thoracotomy. Long-term lead performance and stability were…”
Get more information

Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects by Haggman, D L, Maloney, J D, Morant, V A, Castle, L W, King-Rankine, M, Goormastic, M

Get more information

Electrophysiologic determinants and clinical experience in termination of sustained ventricular tachycardia by Adams, K V, Raju, N V, Sterba, R, Castle, L W, Morant, V A, Maloney, J D

Get more information

Technology-Enabled Assessment of Functional Health by Cook, Diane J., Schmitter-Edgecombe, Maureen, Jonsson, Linus, Morant, Anne V.

“…The maturation of pervasive computing technologies has dramatically altered the face of healthcare. With the introduction of mobile devices, body area…”
Get full text

Implantable cardioverter defibrillator implanted by nonthoracotomy approach: initial clinical experience with the redesigned transvenous lead system by Moore, S L, Maloney, J D, Edel, T B, McGuinn, W P, Gohn, D, Morant, V A, Trohman, R, Simmons, T W, Wilkoff, B L, Castle, L W

“…Standard implantation procedure for the implantable cardioverter defibrillator (ICD) has traditionally required a thoracotomy approach. A newly revised…”
Get more information

Long-term performance of epimyocardial pacing leads in adults: comparison with endocardial leads by Helguera, M E, Maloney, J D, Woscoboinik, J R, Trohman, R G, McCarthy, P M, Morant, V A, Wilkoff, B L, Castle, L W, Pinski, S L

“…The long-term performance of epimyocardial pacing leads in children is well established, but few studies have analyzed the performance in adults. This issue…”
Get more information

Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function by Hughes, M M, Trohman, R G, Simmons, T W, Castle, L W, Wilkoff, B L, Morant, V A, Maloney, J D

“…Concerns about the safety and efficacy of class IC antiarrhythmic agents have arisen as a result of the recent CAST data. We reviewed records of 175…”
Get more information

The use of beep-o-grams in the assessment of automatic implantable cardioverter defibrillator sensing function by Ballas, S L, Rashidi, R, McAlister, H, Corbelli, R, McCowan, R, Wilkoff, B L, Castle, L W, Morant, V A, Simmons, T W, Maloney, J D

“…Noninvasive assessment of sensing performance in the automatic implantable cardioverter defibrillator is limited by the absence of telemetry or memory…”
Get more information

Design-dependent cross-talk in a second generation DDD pacemaker by Beaver, B B, Maloney, J D, Castle, L W, Morant, V A, Keefe, J M, Ching, E

“…A unique mechanism of "cross-talk" has recently been described in the Gemini 415A DDD pacemaker in which cross-inhibition of the ventricular output stimulus…”
Get more information

Six-year clinical experience with the automatic implantable cardioverter defibrillator by Edel, T B, Maloney, J D, Moore, S, McGuinn, W P, Gohn, D, Williams, D, Wilkoff, B L, McCarthy, P, Morant, V A, Pearce, G

Get more information

Noninvasive assessment of ventriculo-atrial conduction and early experience with the tachycardia termination algorithm in pacemaker-mediated tachycardia by Fontaine, J M, Maloney, J D, Castle, L W, Morant, V A

“…Since the advent of physiologic dual chamber pacing systems, pacemaker-mediated tachycardia (PMT) has occurred and the need for invasive measurement of…”
Get more information